The question requires us to identify the factors that could lead to pharmacokinetic drug interactions. Pharmacokinetics involves the movement of drugs within the body and includes processes such as absorption, distribution, metabolism, and excretion. Let's evaluate each option:
Based on the analysis above, options A, B, and D are related to pharmacokinetic processes. Thus, the correct answer is A, B, and D only.
| List I-Mechanism of action | List II-Drugs | ||
| A | DPP4 inhibitors | I | Metformin |
| B | KATP Channel blocker | II | Pioglitazone |
| C | PPAR activator | III | Glimepiride |
| D | AMP Activator | IV | Teneligliptin |
| E | - | V | α glucosidase inhibitors |
Choose the correct answer from the options given below:
| List I | List II | ||
| A | Phase‐I | I | Post marketing surveillance |
| B | Phase‐0 | II | Micro dosing |
| C | Phase‐3 | III | First in human dose |
| D | Phase‐4 | IV | Multicentric trials |
Choose the correct answer from the options given below:
List I | List II | ||
|---|---|---|---|
| A | \(\Omega^{-1}\) | I | Specific conductance |
| B | \(∧\) | II | Electrical conductance |
| C | k | III | Specific resistance |
| D | \(\rho\) | IV | Equivalent conductance |
List I | List II | ||
|---|---|---|---|
| A | Constant heat (q = 0) | I | Isothermal |
| B | Reversible process at constant temperature (dT = 0) | II | Isometric |
| C | Constant volume (dV = 0) | III | Adiabatic |
| D | Constant pressure (dP = 0) | IV | Isobar |